Magnesium sulphate is not effective for reducing the risk of preterm birth and its may use may increase the risk of mortality
Although the use of probiotics is effective in treatment of vaginal infection, currently there is no evidence to support its use for preventing preterm labour.
Current evidence regarding the choice of mode of birth in women with a previous caesarean section is limited.
The evidence for the use of intrapartum antibiotics for known maternal Group B streptococcal colonization is lacking.
There is not enough evidence to recommend relaxation as a treatment for perimenopausal or postmenopausal symptoms.
Until better quality data become available, women with asymptomatic bacteriuria in pregnancy should be treated with the standard seven-day antibacterial regimen.
Currently there is no evidence to recommend extra fluid intake for breast-feeding mothers in order to increase milk production.
Oral misoprostol is as an effective agent for induction of labour. Compared with vaginal dinoprost or oxytocin, misoprostol use results in less frequent use of caesarean section.
Betamimetics delay preterm labour, but are associated with multiple adverse effects.
Current evidence does not support the administration of tocolysis for women with preterm premature rupture of membranes (PPROM).
In twin pregnancies, compared with expectant management, elective births at 37 weeks’ gestation is not associated with increased risks of adverse outcomes.
Health-care practice guidance from WHO and other institutions
Methodological and education resources for improved understanding of the concepts and discussions related to generation of best evidence
A set of training videos to help clinicians master details of manual or surgical procedures
Available for iPad, the RHL app allows you to access the entire library offline